The Patent Finder

Merk & Co., Inc.

Also on record
Records under this name other than patents Merk & Co., Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 10 of 10 · Back to Merk & Co., Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,141,398Methods for Recycling Mrna for Linear Crna Amplification
Formerly held
Term ended
Term ended Jul 31, 2024 · High confidence
Term endedTerm ended Jul 31, 2024High confidence
US 7,432,084Methods for Preparing Nucleic Acid Samples Useful Screening DNA Arrays
Formerly held
Term ended
Term ended Jun 12, 2023 · High confidence
Term endedTerm ended Jun 12, 2023High confidence
US 7,229,765Random-Primed Reverse Transcriptase-In Vitro Transcription Method for RNA Amplification
Formerly held
Term ended
Term ended May 6, 2023 · High confidence
Term endedTerm ended May 6, 2023High confidence
US 6,605,720Process for Making Spirolactone Compounds
Formerly held
Term ended
Term ended Jan 23, 2023 · High confidence
Term endedTerm ended Jan 23, 2023High confidence
US 6,271,002RNA amplification method
Formerly held
Term ended
Term ended Oct 4, 2019 · USPTO record
Term endedTerm ended Oct 4, 2019USPTO record
US 7,084,134Thrombin Inhibitors
Held by another company
Lapsed on the fee record
Ended Aug 1, 2014 · High confidence
Lapsed on the fee recordEnded Aug 1, 2014High confidence
US 7,220,720Melanin-Concentrating Hormone Analogs
Held by another company
Lapsed on the fee record
Ended May 22, 2011 · High confidence
Lapsed on the fee recordEnded May 22, 2011High confidence
US 7,196,163Assays Using Amyloid Precursor Proteins with Modified Beta-Secretase Cleavage Sites to Monitor Beta-Secretase Activity
Held by another company
Lapsed on the fee record
Ended Mar 27, 2011 · Medium confidence
Lapsed on the fee recordEnded Mar 27, 2011Medium confidence
US 4,438,123Ophthalmic compositions of carbonic anhydrase inhibitors for topical application in the treatment of elevated intraocular pressure
Term ended
Term ended no later than Mar 20, 2004 · Low confidence
Term endedTerm ended no later than Mar 20, 2004Low confidence
US 5,872,135Inhibitors of farnesyl-protein transferase
Term ended
Term ended no later than Feb 16, 2019 · Low confidence
Term endedTerm ended no later than Feb 16, 2019Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited